Latest filing published 18 Aug 2023 for Marksans Pharma Limited, €3,797.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Arvind Singh: trading record in brief
Arvind Singh discloses dealings in Marksans Pharma Limited to SEBI (PIT + SAST). We count 8 filings, every one of them for a trade on 14 August 2023.
The open-market side counts 2 purchases for €7,649 alongside 6 sales for €32k. On balance, insiders were net sellers of €24k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The record was last updated on 18 August 2023 with an open-market sale (€3,797) in Marksans Pharma Limited. The latest purchase dates back some time: it was published 1,178 days ago, on 18 August 2023. The median gap between a trade and its publication by SEBI (PIT + SAST) is 4 days. The shorter that gap, the sooner other investors can see what insiders have done. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEBI (PIT + SAST) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Arvind Singh
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,000 shares@ ₹114.901719.4% of flowEquity SharesSEBI:2e2ad155d75bcf305923ea669f20b6a56aae7c3c
- 2,000 shares@ ₹163.921518.4% of flowEquity SharesSEBI:2fd199b725b329c9c77b357c4ed02f432ee90b37
- 6,500 shares@ ₹117.055242.7% of flowEquity SharesSEBI:f3f5c625f259ef795f1df82964f7141dd79b25e9
- 3,000 shares@ ₹115.7519.5% of flowEquity SharesSEBI:446619a36ecdecb12d4ddac15e4d4728e148189eCanonical exit: 12 Nov 2023 (T+90)
4 of 4 declarations